Biodel (BIOD) Momentum Indicators; Time to Look at Goldman Sachs (GS)


The price of Biodel Inc. (Nasdaq:BIOD) stock soared more than 17% before the opening bell Monday as the company said that the FDA removed the partial clinical hold and gave the green light to continue its previously initiated Phase 2b Study 3-250 for BIOD-531

BIOD stock closed at $0.425 on Friday

Biodel, a specialty biopharmaceutical company, has 62.15M Shares Outstanding, Market Capitalization (intraday) of $26.41M and BIOD stock 52-week range is between $0.39 and $2.00 per share



Shares of Goldman Sachs Group, Inc. (NYSE:GS) surged over 1% on Monday’s pre-market trading activity after analysts at Citicgroup upgraded the company’s stock from a Neutral to a Buy rating

Goldman Sachs stock finished Friday at $179.19 per share

Goldman Sachs, an investment banking, securities, and investment management company, has 451.50M Shares Outstanding, Market Capitalization (intraday) of $80.90B and GS stock 52-week range is $167.49 – $218.77 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at